WO1998036730A3 - Compositions for treating acne rosacea - Google Patents
Compositions for treating acne rosacea Download PDFInfo
- Publication number
- WO1998036730A3 WO1998036730A3 PCT/EP1998/000991 EP9800991W WO9836730A3 WO 1998036730 A3 WO1998036730 A3 WO 1998036730A3 EP 9800991 W EP9800991 W EP 9800991W WO 9836730 A3 WO9836730 A3 WO 9836730A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- compositions
- acne rosacea
- treating acne
- rosacea
- prevention
- Prior art date
Links
- 201000004700 rosacea Diseases 0.000 title abstract 3
- 239000000203 mixture Substances 0.000 title 1
- 102000008299 Nitric Oxide Synthase Human genes 0.000 abstract 1
- 108010021487 Nitric Oxide Synthase Proteins 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 230000000699 topical effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/74—Biological properties of particular ingredients
- A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
- A61K2800/782—Enzyme inhibitors; Enzyme antagonists
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Toxicology (AREA)
- Cosmetics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP53626998A JP2001512471A (en) | 1997-02-21 | 1998-02-20 | Preparations for the treatment of rosacea |
EP98913571A EP0969790A2 (en) | 1997-02-21 | 1998-02-20 | Compositions for treating acne rosacea |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19706581.3 | 1997-02-21 | ||
DE19706581 | 1997-02-21 | ||
DE19711565A DE19711565A1 (en) | 1997-02-21 | 1997-03-20 | Preparations for the treatment of rosacea |
DE19711565.9 | 1997-03-20 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO1998036730A2 WO1998036730A2 (en) | 1998-08-27 |
WO1998036730A3 true WO1998036730A3 (en) | 1998-10-22 |
Family
ID=26034114
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP1998/000991 WO1998036730A2 (en) | 1997-02-21 | 1998-02-20 | Compositions for treating acne rosacea |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP0969790A2 (en) |
JP (1) | JP2001512471A (en) |
WO (1) | WO1998036730A2 (en) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19918750A1 (en) * | 1999-04-24 | 2000-10-26 | Beiersdorf Ag | Active ingredients, cosmetic and dermatological preparations for improving the barrier function |
FR2794974B1 (en) * | 1999-06-16 | 2001-08-17 | Exsymol Sa | COSMETIC COMPOSITION FOR SLIMMING BASED ON L-ARGININE, AN ANALOG OF L-ARGININE OR A DERIVATIVE THEREOF, APPLICABLE TOPICALLY |
FR2808189B1 (en) * | 2000-04-28 | 2004-03-05 | Oreal | LIPOCHROMAN-6 AS NO-SYNTHASE INHIBITOR AND USES |
US7439241B2 (en) | 2003-05-27 | 2008-10-21 | Galderma Laboratories, Inc. | Compounds, formulations, and methods for treating or preventing rosacea |
US8410102B2 (en) | 2003-05-27 | 2013-04-02 | Galderma Laboratories Inc. | Methods and compositions for treating or preventing erythema |
US20050020600A1 (en) | 2003-07-23 | 2005-01-27 | Scherer Warren J. | Methods of treating cutaneous flushing using selective alpha-2-adrenergic receptor agonists |
KR20100016341A (en) | 2004-09-02 | 2010-02-12 | 에스비아이 아라프로모 가부시키가이샤 | Constitutional function-improving agents |
JP4814568B2 (en) * | 2004-09-02 | 2011-11-16 | コスモ石油株式会社 | Immune function improver |
JP4814567B2 (en) * | 2004-09-02 | 2011-11-16 | コスモ石油株式会社 | Health function improver |
JP4814501B2 (en) * | 2004-09-02 | 2011-11-16 | コスモ石油株式会社 | Antioxidant function improver |
EP2091325B1 (en) | 2006-10-12 | 2014-08-06 | Topaz Pharmaceuticals Inc. | Shampoo-conditioner formulations comprising an avermectin for elimination of, and prophylaxis against, susceptible and treatment-resistant strains of lice |
EP2116237A1 (en) * | 2008-08-05 | 2009-11-11 | Polichem SA | Compositions for treating rosacea comprising chitosan and a dicarboxylic acid |
JP2011063541A (en) * | 2009-09-17 | 2011-03-31 | Tokyo Institute Of Technology | Purification method of l-arginine-binding factor and screening method of l-arginine-like compound |
EP2329849B1 (en) | 2009-11-18 | 2015-04-29 | Galderma Research & Development | Combination of alpha-2 adrenergic receptor agonist and non-steroidal anti-inflammatory agent for treating or preventing an inflammatory skin disorder |
US8394800B2 (en) | 2009-11-19 | 2013-03-12 | Galderma Laboratories, L.P. | Method for treating psoriasis |
WO2011117378A2 (en) | 2010-03-26 | 2011-09-29 | Galderma Research & Development | Improved methods and compositions for safe and effective treatment of telangiectasia |
WO2011117377A2 (en) | 2010-03-26 | 2011-09-29 | Galderma Research & Development | Improved methods and compositions for safe and effective treatment of erythema |
US8053427B1 (en) | 2010-10-21 | 2011-11-08 | Galderma R&D SNC | Brimonidine gel composition |
JP2013540143A (en) | 2010-10-21 | 2013-10-31 | ガルデルマ・ソシエテ・アノニム | Brimonidine gel composition and method of use |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0631776A1 (en) * | 1993-07-02 | 1995-01-04 | Roussel Uclaf | Use of beta-naphthoquinone for accelerating the proliferation of endothelial cells and inhibiting no synthases |
WO1995024884A1 (en) * | 1994-03-16 | 1995-09-21 | Handelman, Joseph, H. | Inhibition of hair growth |
WO1996026711A1 (en) * | 1995-02-27 | 1996-09-06 | L'oreal | Nitric oxide synthase inhibitors |
WO1997015280A1 (en) * | 1995-10-26 | 1997-05-01 | L'oreal | Use of at least one no synthase inhibitor for treating sensitive skin |
FR2744915A1 (en) * | 1996-02-16 | 1997-08-22 | Oreal | Skin or hair treatment composition |
-
1998
- 1998-02-20 WO PCT/EP1998/000991 patent/WO1998036730A2/en not_active Application Discontinuation
- 1998-02-20 JP JP53626998A patent/JP2001512471A/en active Pending
- 1998-02-20 EP EP98913571A patent/EP0969790A2/en not_active Withdrawn
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0631776A1 (en) * | 1993-07-02 | 1995-01-04 | Roussel Uclaf | Use of beta-naphthoquinone for accelerating the proliferation of endothelial cells and inhibiting no synthases |
WO1995024884A1 (en) * | 1994-03-16 | 1995-09-21 | Handelman, Joseph, H. | Inhibition of hair growth |
WO1996026711A1 (en) * | 1995-02-27 | 1996-09-06 | L'oreal | Nitric oxide synthase inhibitors |
WO1997015280A1 (en) * | 1995-10-26 | 1997-05-01 | L'oreal | Use of at least one no synthase inhibitor for treating sensitive skin |
FR2744915A1 (en) * | 1996-02-16 | 1997-08-22 | Oreal | Skin or hair treatment composition |
Non-Patent Citations (3)
Title |
---|
A.A.QURESHI ET AL.: "From Bedside to the Bench and Back", ARCH. DERMATOL., vol. 132, no. 8, August 1996 (1996-08-01), pages 889 - 903, XP002075669 * |
G.SAUERMANN ET AL.: "Influence of NO-Synthase Antagonists in Rosacea Patients", J.INVEST DERMATOL., vol. 108, no. 4, April 1997 (1997-04-01), pages 657, XP002075670 * |
S.M.BIRNBAUM ET AL.: "Preparation of the Optical Isomers of Arginine, Histidine and S-Benzylcysteine by Asymmetric Enzymatic Hydrolysis of their Acetyl Derivatives", ARCH.BIOCHEM., vol. 39, 1952, pages 108 - 118, XP002075668 * |
Also Published As
Publication number | Publication date |
---|---|
JP2001512471A (en) | 2001-08-21 |
EP0969790A2 (en) | 2000-01-12 |
WO1998036730A2 (en) | 1998-08-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO1998036730A3 (en) | Compositions for treating acne rosacea | |
CA2267186A1 (en) | Method of using cyclooxygenase-2 inhibitors in the treatment and prevention of neoplasia | |
ZA981132B (en) | Methods, compositions and articles for reducing or preventing the effects of inflammation. | |
WO2002072031A3 (en) | Substituted tetracycline compounds as synergistic antifungal agents | |
WO2002047706A3 (en) | Selective cox-2 inhibition from plant extracts | |
WO1996021655A3 (en) | Substituted oxazolidine calpain and/or cathepsin b inhibitors | |
WO2000037107A3 (en) | Use of cyclooxygenase-2 inhibitor, a matrix metallaproteinase inhibitor, an antineoplastic agent and optionally radiation as a combination treatment of neoplasia | |
WO2001051043A3 (en) | Compositions and methods for treatment of neoplastic diseases with combinations of limonoids, flavonoids and tocotrienols | |
WO2003053383A3 (en) | Cosmetic use of at least a hydrophobin for treating keratinous materials | |
CA2257010A1 (en) | Methods and compositions for the treatment and prevention of tumors, tumor-related disorders and cachexia | |
WO1994004541A3 (en) | Protein kinase inhibitors and related compounds combined with taxol | |
ZA973487B (en) | Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment. | |
WO2001017543A3 (en) | Compositions and methods for the prevention or treatment of cancer and bone loss associated with cancer | |
WO2000009101A3 (en) | Use of estrogenic compounds as anti-fungal agents | |
WO1997004788A3 (en) | Use of calendula glycosides for the treatment of psoriasis | |
WO2000021513A3 (en) | Methods for treating multiple sclerosis | |
AU8853998A (en) | Composition comprising vitamin k and vitamin d, for treating or preventing osteoporosis | |
AU2002232400A1 (en) | Reversed amidines and methods of using for treating, preventing, or inhibiting leishmaniasis | |
CA2275167A1 (en) | The topical use of kappa opioid agonists to treat ocular pain | |
WO1998018440A3 (en) | Use of inhibitors of the activity of retinoic acid for treating sensitive skin | |
WO1998022101A3 (en) | Method of using cyclooxygenase-2 inhibitors as anti-angiogenic agents | |
EP1171145A4 (en) | Use of catechin for preventing or treating coronary restenosis | |
CA2200126A1 (en) | Treatment and prophylaxis of pancreatitis | |
WO2000032765A3 (en) | Ribozyme therapy for the treatment and/or prevention of restenosis | |
WO2000040232A3 (en) | Bretylium compositions and kits, and their use in preventing and treating cardiovascular conditions |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): JP US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): JP US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 1998913571 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref country code: JP Ref document number: 1998 536269 Kind code of ref document: A Format of ref document f/p: F |
|
WWE | Wipo information: entry into national phase |
Ref document number: 09367748 Country of ref document: US |
|
WWP | Wipo information: published in national office |
Ref document number: 1998913571 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1998913571 Country of ref document: EP |